Use of mycophenolate mofetil and a calcineurin inhibitor in allogeneic hematopoietic stem-cell transplantation from HLA-matched siblings or unrelated volunteer donors: Japanese multicenter phase II trials - Nakane, Takahiko; Nakamae, Hirohisa; Yamaguchi, Takuhiro; Kurosawa, Saiko; Okamura, Atsuo; Hidaka, Michihiro; Fuji, Shigeo; Kohno, Akio; Saito, Takeshi; Aoyama, Yasutaka; Hatanaka, Kazuo; Katayama, Yoshio; et al. (International journal of hematology, 2017)
Keywords: Adult; Aged; Calcineurin Inhibitors - administration & dosage; Female; Graft Survival - drug effects; Graft vs Host Disease - drug therapy; Graft vs Host Disease - prevention & control; Hematology; Hematopoietic Stem Cell Transplantation - methods; Histocompatibility; HLA Antigens - immunology; Humans; Japan; Male; Medicine; Medicine & Public Health; Middle Aged; Mucositis - prevention & control; Mycophenolic Acid - administration & dosage; Oncology; Original Article; Siblings; Transplantation, Homologous; Unrelated Donors; Volunteers; Graft-versus-host disease prophylaxis; Allogeneic hematopoietic stem-cell transplantation; Mycophenolate mofetil